NEW YORK, MONTREAL, July 20 /PRNewswire-FirstCall/ -- ICBS Ltd. (OTCPK: ICBT), announced today that it will be establishing a manufacturing center in Canada for international distribution of the TOGS 9000 bio-photonic incubation detection systems.
The company will be applying for investment funds in the amount of 2.5 million dollars from the Canadian government to establish a manufacturing and assembly center in Canada. The center will supply machines to U.S. and international distributors.
BioSpec Global Solutions has developed state-of-the-art technologies for rapid, onsite (remote) monitoring of microbial contamination in drinking water, recreational water, agriculture food production, pharmaceuticals and medical applications. The TOGS 9000 is a bio-photonic incubation/detection instrument which quantifies microbial contamination. The analysis results can be obtained directly on-site through a computer or can be directly connected and controlled by an appropriate laboratory and or regulatory authority in a secure monitoring system using 'AGACSS(TM)' software and the internet.
As an example, The EPA could literally monitor all drinking water sources down to the individual well owner and do it quickly, accurately and cost effectively. Or the Center for Infectious Diseases ( CID ) could monitor the spread of antibiotic resistant microbes (ARMs) across the U.S. at the patient level.
BIOSPEC technology is recognized as the method for the detecting of microbial contamination. By entering in to a series of license agreements with well positioned companies (industry leaders), intellectual property protected, and its varied applications and global use realized.
The company holds worldwide patents on the TOGS 3000 and 9000.
NB. This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.
Inter Canadian Business Service
CONTACT: Don Saunders, President CEO, (514) 932-4402; http://www.icbs.ca/;
Source: BioSpec Global Solutions Inc.
